Large intergenic non-coding RNA-ROR reverses Gemcitabineinduced autophagy and apoptosis in breast cancer cells

47Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

Abstract

The purpose of this study was to elucidate the potential role of long intergenic non-protein coding RNA, regulator of reprogramming (linc-ROR) in gemcitabine (Gem)-induced autophagy and apoptosis in breast cancer cells. MDA-MB-231 cells were treated with short hairpin RNA (shRNA) to knockdown Linc-ROR expression in the presence of Gem. Gem treatment alone decreased cell survival and increased both apoptosis and autophagy. Gem treatment also increased the expression of LC3-II, Beclin 1, NOTCH1 and Bcl-2, but decreased expression of p62 and p53. Untreated MDAMB- 231 cell lines strongly expressed linc-ROR, but linc-ROR knockdown decreased cell viability and expression of p62 and p53 while increasing apoptosis. Linc-ROR knockdown also increased LC3-II/β-actin, Beclin 1, NOTCH1, and Bcl-2 expression, as well as the number of autophagic vesicles in MDA-MB-231 cells. Linc-ROR negatively regulated miR-34a expression by inhibiting histone H3 acetylation in the miR-34a promoter. We conclude that linc-ROR suppresses Gem-induced autophagy and apoptosis in breast cancer cells by silencing miR-34a expression.

Cite

CITATION STYLE

APA

Chen, Y. M., Liu, Y., Wei, H. Y., Lv, K. Z., & Fu, P. F. (2016). Large intergenic non-coding RNA-ROR reverses Gemcitabineinduced autophagy and apoptosis in breast cancer cells. Oncotarget, 7(37), 59604–59617. https://doi.org/10.18632/oncotarget.10730

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free